Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

IGF-1R may play a role in female hair loss and could be a treatment target.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Certain gene variations are not a major cause of male infertility in Nigerian men.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Blocking neurosteroid production can lead to more seizures and faster epilepsy onset in rats.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Ptch2 plays a key role in controlling stem cell function and the ability to regenerate after birth.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

Melatonin applied to the scalp helps increase hair density in people with early hair loss.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.